Screener
Pulse Biosciences, Inc. PLSE Business Segments — Nonoperating Income Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cross platform research and engineering2 | 6,078 | 4,585 | 11,258 | 8,535 |
| R&D manufacturing and engineering3 | 3,201 | 2,941 | 5,550 | 4,736 |
| Clinical and regulatory4 | 5,127 | 2,183 | 8,387 | 3,943 |
| General and administrative5 | 4,548 | 2,742 | 8,490 | 5,461 |
| Sales and marketing6 | 1,279 | 2,362 | 3,607 | 4,218 |
| Other segment items7 | 5,228 | 5,462 | 7,394 | 11,426 |
| Total other income, net | (615) | (1,107) | (1,184) | (2,356) |
| Net loss | $(24,657) | $(19,168) | $(43,238) | $(35,963) |
Document
FAQ
- What is Pulse Biosciences, Inc.'s business segments — nonoperating income expense?
- Pulse Biosciences, Inc. (PLSE) reported business segments — nonoperating income expense of -$615K in Q2 2026.
- What does business segments — nonoperating income expense mean?
- This includes financial results from activities outside of the company's core business operations, such as interest income, interest expense, or foreign currency adjustments. It provides a view of the company's financial health independent of its primary commercial activities.
Ask your AI about Pulse Biosciences, Inc.'s business segments — nonoperating income expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude